The Week Ahead: COS...
Health Care: Drugs
Celgene Corporation (CELG: NASDAQ)
$122.58 -1.06 | -0.86%
05/24/13 - 04:00 PM ET
Portfolios with CELG
- Portfolio NameUser Type
- Userdennis all star
- Userportfolio 1.1
- UserCraigMcIlquham
- User4 Overvalued Biotechs
- ProRay Dalio - Bridgewater Ass...
- ProBill Miller - Legg Mason Ca...
- ContributorStocks Rising On Unusual Vo...
- UserTest Portfolio
- UserMike Fatah's Mega Stock Por...
- User2012 Allocation
Latest CELG Headlines from TheStreet
- 5 Stocks Raising The Drugs Industry Higher 05.23.13 | 01:05 pm
- Cramer's 'Mad Money' Recap: Ignore the Fed 05.22.13 | 07:05 pm
- Cramer: A Pile of Simply Horrendous Advice 05.20.13 | 11:05 am
- Celgene Corporation (CELG): Today's Featured Health Care Winner 05.17.13 | 05:05 pm
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward 05.16.13 | 01:05 pm
- Cramer's 'Mad Money' Recap: Stick With What Works 05.14.13 | 08:05 pm
- Celgene Stock Hits New 52-Week High (CELG) 05.13.13 | 10:05 am
- Celgene Corporation (CELG): Today's Featured Drugs Winner 05.10.13 | 05:05 pm
- Cramer: Biotech Makes a Comeback 05.10.13 | 04:05 pm
- 5 Stocks Advancing The Drugs Industry 05.07.13 | 01:05 pm
Press Releases for CELG
- Celgene Corporation To Webcast At Two Upcoming Investor Conferences And The American Academy Of Dermatology Annual Meeting - Business Wire 02.28.13 | 08:02 am
- Celgene Announces $600 Million Accelerated Share Repurchase Program - Business Wire 02.20.13 | 08:02 am
- Celgene Provides REVLIMID® Regulatory Update - Business Wire 02.11.13 | 07:02 am
- POMALYST(R) Brand Therapy (Photo: Business Wire) - Business Wire 02.08.13 | 03:02 pm
- Celgene Corporation To Webcast At Upcoming Investor Conferences - Business Wire 02.04.13 | 08:02 am
- Celgene Reports Strong Fourth Quarter And Full Year 2012 Operating And Financial Results - Business Wire 01.24.13 | 07:01 am
- The True Effect: Positive Findings - Research Report On Celgene Corporation And Gilead Sciences, Inc. - PR Newswire 01.23.13 | 08:01 am
- ABRAXANE® Plus Gemcitabine Demonstrates Significant Survival Advantage In Phase III Study Of Patients With Advanced Pancreatic Cancer - Business Wire 01.22.13 | 06:01 pm
- Celgene Corporation Announces Financial Outlook And Preliminary 2012 Results - Business Wire 01.07.13 | 11:01 am
- Celgene Corporation To Present At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 12.21.12 | 08:12 am
Partner Headlines for CELG
- Bristol-Myers, Jazz Pharmaceuticals Lead Pharma Rally - Investor's Business Daily 05.22.13 | 05:05 pm
- Stocks Reverse Lower On Fears That Fed May Pare Easing - Investor's Business Daily 05.22.13 | 05:05 pm
- Stocks Stage Broad Advance; Bristol-Myers Leads Medicals - Investor's Business Daily 05.22.13 | 12:05 pm
- Market Close Report: NASDAQ Composite index closes at 3,465.24 down -6.38 points - NASDAQ 05.16.13 | 08:05 pm
- Stocks Close Lower; Dell Little Changed After Earnings - Investor's Business Daily 05.16.13 | 05:05 pm
- Wall Street Turns Down At The Bell; Celgene Sells Off - Investor's Business Daily 05.16.13 | 04:05 pm
- Stocks Flat In Late Trading, But Cisco Lifts Nasdaq - Investor's Business Daily 05.16.13 | 03:05 pm
- Stocks Little Changed; Qihoo, Ocwen Hit New Highs - Investor's Business Daily 05.16.13 | 01:05 pm
- Top-Rated Big-Cap Stocks Rising With Robust Market - Investor's Business Daily 05.13.13 | 05:05 pm
- Stocks End Mixed In Quiet Trade; Stratasys Leads 3D Rally - Investor's Business Daily 05.13.13 | 04:05 pm
